1. A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR.
- Author
-
Arellano, Benjamine, Hussain, Rehana, Miller-Little, William A, Herndon, Emily, Lambracht-Washington, Doris, Eagar, Todd N, Lewis, Robert, Healey, Don, Vernino, Steven, Greenberg, Benjamin M, and Stüve, Olaf
- Subjects
CD4-Positive T-Lymphocytes ,Animals ,Mice ,Inbred C57BL ,Mice ,Transgenic ,Humans ,Neuromyelitis Optica ,Encephalomyelitis ,Autoimmune ,Experimental ,Disease Models ,Animal ,Receptors ,Antigen ,T-Cell ,Vaccination ,Amino Acid Substitution ,Cell Differentiation ,Cell Proliferation ,Amino Acid Sequence ,Molecular Sequence Data ,Female ,Aquaporin 4 ,HLA-DRB1 Chains ,Disease Models ,Animal ,Encephalomyelitis ,Autoimmune ,Experimental ,Mice ,Inbred C57BL ,Transgenic ,Receptors ,Antigen ,T-Cell ,General Science & Technology - Abstract
BackgroundAquaporin 4 (AQP4) is considered a putative autoantigen in patients with Neuromyelitis optica (NMO), an autoinflammatory disorder of the central nervous system (CNS). HLA haplotype analyses of patients with NMO suggest a positive association with HLA-DRB1* 03:01. We previously showed that the human (h) AQP4 peptide 281-300 is the dominant immunogenic determinant of hAQP4 in the context of HLA-DRB1*03:01. This immunogenic peptide stimulates a strong Th1 and Th17 immune response. AQP4281-300-specific encephalitogenic CD4+ T cells should initiate CNS inflammation that results in a clinical phenotype in HLA-DRB1*03:01 transgenic mice.MethodsControlled study with humanized experimental animals. HLA-DRB1*03:01 transgenic mice were immunized with hAQP4281-300, or whole-length hAQP4 protein emulsified in complete Freund's adjuvant. Humoral immune responses to both antigens were assessed longitudinally. In vivo T cell frequencies were assessed by tetramer staining. Mice were followed clinically, and the anterior visual pathway was tested by pupillometry. CNS tissue was examined histologically post-mortem. Flow cytometry was utilized for MHC binding assays and to immunophenotype T cells, and T cell frequencies were determined by ELISpot assay.ResultsImmunization with hAQP4281-300 resulted in an in vivo expansion of antigen-specific CD4+ T cells, and an immunoglobulin isotype switch. HLA-DRB1*03:01 TG mice actively immunized with hAQP4281-300, or with whole-length hAQP4 protein were resistant to developing a neurological disease that resembles NMO. Experimental mice show no histological evidence of CNS inflammation, nor change in pupillary responses. Subsequent analysis reveals that a single amino acid substitution from aspartic acid in hAQP4 to glutamic acid in murine (m)AQP4 at position 290 prevents the recognition of hAQP4281-300 by the murine T cell receptor (TCR).ConclusionInduction of a CNS inflammatory autoimmune disorder by active immunization of HLA-DRB1*03:01 TG mice with human hAQP4281-300 will be complex due to a single amino acid substitution. The pathogenic role of T cells in this disorder remains critical despite these observations.
- Published
- 2016